Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-076431
Filing Date
2025-04-09
Accepted
2025-04-09 09:51:55
Documents
6
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 6-K d945045d6k.htm 6-K 9542
2 EX-99.1 d945045dex991.htm EX-99.1 379243
3 EX-99.2 d945045dex992.htm EX-99.2 147576
4 EX-99.3 d945045dex993.htm EX-99.3 11914
5 EX-99.4 d945045dex994.htm EX-99.4 11779
6 GRAPHIC g945045g55j35.jpg GRAPHIC 11657
  Complete submission text file 0001193125-25-076431.txt   571918
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 25824098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)